Search
At 25, the Dallas Heart Study is shaping cardiac care and exploring links to brain health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/aug-advancing-heart-health.html
Twenty-five years since its inception, the Dallas Heart Study (DHS) is recognized as one of the leading population-based studies of heart health in the U.S. It has spawned more than 230 research papers and produced major findings that have guided advancements in how cardiovascular disease
Neurons in brain’s timekeeper might control nighttime hunger: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-neurons-brain-timekeeper.html
Activating specific neurons in a part of the brain that serves as the body’s master circadian pacemaker caused mice to eat significantly more during a time of day when they would normally be at rest, a UT Southwestern Medical Center study shows.
Newsroom Archive: 2024 - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/
Stories published in 2024 about UT Southwestern Medical Center.
UT Southwestern No. 1 hospital in Dallas-Fort Worth, Best Hospital rankings show: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-us-news-best-hospital.html
UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth – the nation’s fourth-largest metro area – for the sixth consecutive year and ranks among the top hospitals nationally in nine specialties ranging from brain to heart to cancer care.
Newsroom Archive: 2025 - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/
Stories published in 2025 about UT Southwestern Medical Center.
Most patients support AI to help read mammograms with doctor oversight: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-ai-mammograms.html
Artificial intelligence (AI) has become a go-to tool in health care, helping clinicians such as radiologists make diagnoses and personalize care. But what do patients think about this?
FDA approval of belzutifan culminates 25-year journey at UTSW from gene discovery to a first-in-class drug: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/fda-approval-belzutifan.html
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.
Simmons Cancer Center earns exceptional rating in its renewal as an NCI-designated Comprehensive Cancer Center: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-simmons-cancer-center-renewal-comprehensive-cancer-center.html
The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern earned exemplary marks as part of the renewal of its comprehensive designation by the National Cancer Institute (NCI).
UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Japan Prize: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-chen-japan-prize.html
Zhijian “James” Chen, Ph.D., Professor of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on how the body’s immune system protects us against threats such as bacteria and viruses, has been awarded the 2026 Japan Prize in Life Sciences – one of the highest
Media Relations: Newsroom - UT Southwestern
https://www.utsouthwestern.edu/newsroom/media-relations/
Information for media relations with UT Southwestern